OUR BOARD OF
DIRECTORS

Our Board of Directors is comprised of key investors who provide leadership through corporate governance and strategic support of our vision and overall strategy.

BRAD WERTZ

Chairman and CEO

Formerly the President and COO of Rosetta, Brad helped grow the company from $115M to $225M before its sale to Publicis. Before Rosetta, He served as COO for Brulant and also held senior executive positions at several other startups including bioinformatics company Acero. 

LEE ZAPIS

Board Member

Lee is the President of Zapis Capital Group, a closely held corporation that makes equity investments in people with passion and expertise to lead their business to success. He is a hands-on investor and currently sits on the boards of GenomOncology, YouBeauty.com, and Listener Driven Radio.

LEN PAGON JR.

Board Member

Len is Chairman and CEO of Next Sparc, LLC, which invests in emerging Internet-based, software and services-based companies and helps them achieve significant growth. In addition, Len was the former Vice Chairman of Rosetta and the former Chairman, CEO and founder of Brulant, Inc. 

JONATHAN SEATON

Board Member

Jonathan was most recently the Senior Vice President of Corporate and Business Development / Government Affairs at Illumina. He has previously held leadership roles at F. Hoffman-La Roche, Roche Tissue Diagnostics, LS9, and several consulting firms and investment banks. 

BRIAN LADEN, PH.D.

Board Member

Dr. Laden co-founded TriStar Technology Ventures in 2009, and serves on the board for Molecular Sensing and the Advisory Board for Cumberland Emerging Technologies. He also holds an observer seat on the boards of TVA and BioStable in addition to GenomOncology's board. 

Office

1138 West 9th St Suite 400

Cleveland, OH 44113, USA

(440) 617-6087

CONTACT US

© 2020 GenomOncology LLC